Abstract:
Drug Resistant TB remains a global and national health threat. Ethiopia is among the high TB, TB/HIV and MDRTB
burden
countries
globally.
Cognizant
of
the
burden
and
the
deleterious
health
impacts
of
drug-resistant
TB
in
the
country, the FDRE Ministry of Health (FMOH) has begun responding to the emergence of DR-TB by
conducting the first Drug Resistant TB survey (DRS) in 2005 followed by the establishment of the first DR-TB
treatment center in Addis Ababa in 2009 to treat the first cohorts of DR-TB patients under programmatic
conditions. This was followed by the introduction of ambulatory model of DR-TB and massive expansion of the
DR-TB diagnostic and treatment centers, development of national PMDT guidelines consistent with global
recommendations, and training of health care workers on the clinical and programmatic management of DR-TB.
Substantial gains have been made as the result of the significant investments on Programmatic management of
DR-TB (PMDT).
